< Back to portfolio

Product Description

VoiceMed is developing proprietary algorithms to track asthma with vocal biomarkers using breathing sounds collected from a smartphone. This tech will be an additional medical device software integrated into the Airlyn mobile app, that allows users to change their behaviour to better manage their asthma (leading to increased quality of life, and decreasing asthma attacks), and allow healthcare payers to reduce costs.

This innovation will generate a new data value chain in which users receive their score to track their asthma, download the report and share it with their doctor, who can then have this data to take further decisions.

Usage of Standards for data interoperability:

Airlyn is based on a set of RESTful APIs that facilitate the interaction and integration with third parties, web applications and mobile apps.
The JSON schema is used to define this interaction.

Company Description

Imagine a world where you can monitor your health using only a smartphone. Everywhere, at any time. This is the future with VoiceMed.

With genius life scientists, smart engineers, and passionate patients, Voicemed’s current focus is on developing proprietary algorithms to predict the worsening of asthma with vocal biomarkers. This technology will be integrated into the recently launched app Airlyn that allows users to track and improve their breathing by combining personalised feedback with clinically-proven breathing exercises. By improving asthma self-management, the current solution already allows healthcare insurers to reduce healthcare utilization costs. Voicemed initially targets private insurers, then will apply for regulated reimbursement schemes, securing payment from multiple insurers (e.g. DiGA in Germany). Voicemed makes patients safer, healthier & reduces healthcare costs.